EHC Stock Analysis: Buy, Sell, or Hold?
EHC - Encompass Health Corporation Common Stock
$99.90
1.22 (1.24%)
▲
5d:
+0.54%
30d:
-4.36%
90d:
+2.44%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 03, 2026
Get Alerted When EHC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: EHC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: EHC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$148.79
Based on 6.4% avg growth
INTRINSIC VALUE TODAY
$92.39
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EHC is currently trading at $99.90, which is considered oversold relative to its 30-day fair value range of $100.08 to $105.36. The stock's valuation (Forward PE: 15.1) is in line with its historical norms (16.7). Remarkably, the market is currently pricing in an annual earnings decline of 3.3% over the next few years. This pessimistic expectation contrasts with the company's recent 30.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, EHC is showing sideways momentum. The price is currently testing key support at $99.78. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: EHC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $140.50 (+42.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, EHC is showing sideways momentum. The price is currently testing key support at $99.78. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: EHC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $140.50 (+42.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$100.08 -
$105.36
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 42.4% below Wall St target ($140.50)
Trading Range Analysis
30-Day Trading Range
$100.08 -
$105.36
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$99.78
Resistance Level
$106.92
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.09
Wall Street Target
$140.50
(+42.4%)
Revenue Growth (YoY)
9.0%
Earnings Growth (YoY)
30.3%
Profit Margin
10.0%
Valuation Discount vs History
-3.3% cheaper
PE vs Historical
15.1 vs 16.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.3%
(market-implied from PE analysis)
1-Year Target
$95.42
(-3%)
2-Year Target
$92.27
(-7%)
3-Year Target
$89.23
(-10%)
3-Yr Target (if PE normalizes)
(PE: 15→17)
$98.73
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 8.8%)
$183.45
(+86%)
Base:
(SPY PE: 15.1, Growth: 8.8%)
$127.13
(+29%)
Bear:
(PE: 12.8, Growth: 8.8%)
$108.06
(+10%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 16.79 | Current EPS (TTM): $5.84
Bull Case
$120.72
(+22%)
Analyst growth 11.9%, PE expands to 18.5
Base Case
$109.74
(+11%)
Market implied 11.9%, PE stable at 16.8
Bear Case
$66.66
(-32%)
Severe decline -20.0%, PE contracts to 14.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.1 to 16.7
Stabilization Target:
$109.18
(+10.6%)
PE Expansion Potential:
+10.6%
Share & Embed Analysis
Last updated: June 23, 2026 4:07 PM ET
Data refreshes hourly during market hours. Next update: 5:07 PM
Data refreshes hourly during market hours. Next update: 5:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EHC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Edmund Fay
SELL
11937 shares
2026-03-09
Mark J Tarr
SELL
150000 shares
2026-02-11
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$504 | 58 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 53 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 60 HOLD |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 62 BUY |
